Nephrology & Urology

Dr. Segal received a B.S. degree in Biology from MIT in 1984. As an undergraduate he did research in the laboratory of Dr. Monty Krieger studying the alteration in the glycosylation pattern of a cell line defective in LDL receptor endocytosis. After graduating from MIT, Dr. Segal was accepted into the MSTP M.D./Ph.D. training program at the University of Texas Southwestern Medical School.

Dr. Segal's research focuses on the mechanisms of the increased cardiovascular disease in patients with diabetes, chronic kidney disease, systemic lupus erythematosus (SLE), and women who have preeclampsia or preterm delivery. His hypothesis is that a key determinate of whether an individual will develop chronic kidney disease or atherosclerosis is the ability of the individual's endothelium to tolerate their level of blood pressure, glycemia, or other stressors to the endothelium.

Dr. Allen obtained PhD in Medicine in 1978. For many years he was treated patients with chronic internal diseases, including various kidney problems: nephritis, nephrosis, chronic kidney failure and kidney stones, developing diets for them. Later Dr Allen headed health clinic for the treatment of chronic internal conditions. Then he devoted two decades to further medical research and developed Thermobalancing therapy® and Dr Allen’s Devices for chronic internal diseases, which received a patent in the USA, as “Therapeutic device and method”. He is Director of Fine Treatment, United Kingdom, the Company that distributes these devices worldwide.

chronic internal diseases.

Tong Wang completed her M.D. and clinical trainings at Beijing University, School of Medicine in China. She then spent two postdoctoral training periods in the United States, first at the University of Illinois at Chicago and later at Yale University School of Medicine (with Dr. Gerhard Giebisch). Currently, she is a full Professor, Director of the Small Animal Physiology Core in the Department of Cellular and Molecular Physiology and is co-Director of the Renal Physiology Core in the George M O'Brien Kidney Center at Yale University. She has published more than 100 papers in reputed journals and has been serving as an active member of NIH KMBD study section.

Renal Physiology , Cellular and Molecular Physiology

Riitta Lassila has completed her MD in 1983 from Helsinki University, PhD in 1989, and postdoctoral studies at Mount Sinai University School of Medicine in N.Y. She is an internist and the Head of Coagulation Disorders Unit in Helsinki University Hospital since 2000 and Professor of Coagulation Medicine in Helsinki University since 2013. She has published more than 220 papers in peer-reviewed journals and has served as editor in Thrombosis Research and editorial board member of Haemophilia. She is the secretary of European Association of Haemophilia and Allied Disorders and steering committee member of EUHANET and EUHASS. She is CSO in Aplagon Oy developing APACs as pharamceutical entities.

Coagulation Medicine

In 1987 Dr. Nahman joined the faculty at Ohio State after completing his fellowship at the same institution. In 2004 he became director of the Nephrology division of the University of Florida Jacksonville. In 2010 he joined the Nephrology division at the Medical College of Georgia, where he has directed the Department of Medicine Translational Research Program since 2013, leads a USRDS data mining group, and is PI of a basic research lab studying the tolerogenic properties of the enzyme IDO. In 2017, he became Co-chair of the American Society of Nephrology In-training exam question writing group.

Kidney Transplantation, Haemodialysis, Translational Medicine

Dr. Zhen Su has completed her MD at the age of 25 years from Wenzhou Medical University and has completed her PhD from The Second Military Medical University and postdoctoral studies from Emory University School of Medicine. She is the Vice -Director of renal division in the first affiliated hospital of Wenzhou Medical University. She has published more than 40 papers in reputed journals and had oral presentation in ASN 2005 (American Society of Nephrology) meeting and WCN 2007 (ISN World Congress of Nephrology) meeting.

Nephropathy, Dialysis

Waldo Concepcion, MD, FACS, is a Professor of Pediatric Nephrology and Chief of Clinical Transplantation at Stanford University and Chief of Pediatric Kidney Transplantation at Lucille Packard Children’s Hospital at Stanford. He graduated Medical School from Universidad Autonoma de Guadalajara, Mexico. He then completed his General Surgery Residence at Loma Linda University Medical Center and his Transplantation Surgery Fellowship at University of Pittsburgh under the mentorship of Dr. Thomas Starzl, world leader in the field of transplantation. He is a member of the original team that developed the liver transplant program at California Pacific Medical Center, where he practiced as a transplant surgeon from 1988 to 1994 and is an expert in the field of hepatobiliary and portal hypertension surgery. He and his team moved to Stanford University in 1994. In 1996, he was named director of the Transplantation Institute at Loma Linda University Medical Center where he founded the pediatric liver program and served as Director over the multi-organ transplant program. In 2005, Dr. Concepcion returned to Stanford University to become the new Chief of Clinical Transplantation and Chief of Pediatric Kidney Transplantation at Lucille Packard Children’s Hospital continuing in the tradition of one of the best kidney transplant programs in the world. He has published over 100 articles and book chapters in the scientific literature and remains active in clinical research projects.

Multi-Organ Transplantion (Kidney Transplantation, Pediatric Liver Transplantation, Adult Liver Transplantation, Hepatobiliary Surgery, General Surgery)

Maria Hernandez-Fuentes studied Medicine at Universidad Complutense and then completed PhD in Immunology at Universidad de Alcalá, both in Madrid, Spain. She then moved to the UK, Imperial College London, working on alloimmune responses. In 2005, the research group moved to King’s College London and since then she led the biomarker research group of the MRC Centre for Transplantation. She has a long standing interest in understanding and quantifying alloimmune responses and immune monitoring in kidney transplantation; particularly looking at obtaining evidence of tolerance.

Quantifying alloimmune responses and immune monitoring in kidney transplantation

Dr. David Tovbin has completed his MD at the Hebrew University School of Medicine, Jerusalem, Israel and his nephrology fellowship at Southwestern Medical Center at Dallas, Tx, USA. He is currently Head of Nephrology at Emek Medical Center, Afula, Israel and assistant clinical professor at Faculty of Health Sciences, Technion, Institute of Technology, Haifa, Israel. For the last 7 years Dr Tovbin serves as the head of the Hemodialysis Forum of the Israeli Society of Nephrology and Hypertension.

Acid-base status, anemia and iron deficency correction in hemodialysis patients

Wioletta Dziubek-Rogowska completed her Master of Physiotherapy at University of Physical Education in Wroclaw in 1999 and PhD in Physical Education at University of Physical Education in Wroclaw in 2005. She is Scientist and Adjunct in the Department of Physiotherapy at University of Physical Education in Wroclaw from 2005. From 2007-2016, she was Senior Lecturer and from 2016 to present working as a Professor at Karkonosze College in Jelenia Gora, Faculty of Natural Science and Technology. 2005 - Present - Head of Laboratory of Functional Tests in Internal Diseases, Department of Physiotherapy, and University of Physical Education in Wroclaw. From 01.09.2016-present she is Head of the Scientific Research Laboratory Department of Physiotherapy, University of Physical Education in Wroclaw, from 01.09.2016-present - Rector's Plenipotentiary for the Lower Silesian Science Festival 2007 - Chairman of the Organizing Committee of the VI International Days of Physiotherapy, Wroclaw 2017 - Chairman of the Scientific Committee of the X International Days of Physiotherapy, Wroclaw.

End Stage Renal Disease and Dialysis

Dario Xavier Jimenez Acosta MD. Nephrologist Born in 1977, October 03. Medical Doctor at Central University of Ecuador (1994-2001). Nephrologist by Pichincha Medical College, at Eugenio Espejo Specialty Hospital (2002-2007). Did Nephrology mini fellowship at Colorado University, Denver (2007).He is the Past Secretary of Ecuadorian Society of Nephrology (2012-2015), Medical Director of DIALNEF (Critical Nephrology) Quito-Ecuador (2012-actually). Nephrology Chief at Enrique Grace’s General Hospital (Ecuadorian Health Public Ministry). One book published (coauthor), 16 paper published.

Hemodialysis and Kidney Transplantation

Gakuru Macharia is the Founder Kidney Research Kenya (KRK) KRK has been training doctors, nurses and surgeons through partnership Cairo University, Toledo University USA, Kings College London, Liverpool Teaching Hospital, Hunan Province China. Publisher Author of many books including – Kidney Failure, High Blood Pressure, Kidney Transplantation and Organ Donation, Dialysis, My own Experience. A Bio – Med and has worked for Toshiba Medical Systems Europe and NHS in the UK. He’s also a Journalist and has worked for Kenya Broadcasting as London Bureau Chief, commentator for Aljazeera, CNN, BBC etc.

Kidney Transplantation and Organ Donation, Dialysis

Josep M. Campistol is currently the General Director of the Hospital Clinic of Barcelona, Spain, and former Medical Director of the same hospital as well as Director of the Clinical Institute of Nephrology and Urology (ICNU). He is also Professor of Medicine at the Nephrology Department of the University of Barcelona. He received his medical degree from the University of Barcelona in 1983, and completed his residency in internal medicine and, subsequently, his fellowship in renal medicine at the Hospital Clinic of the same institution. Following his training as a fellow in renal medicine at the University of Barcelona, Prof. Campistol continued his clinical work in renal transplantation within the Renal Transplant Unit at the Hospital Clinic. During this period, he also developed research interests into the pathogenesis of dialysis-related amyloidosis, and undertook a visiting Fulbright Scholarship at Boston University School of Medicine in Boston, MA, USA (1991– 1992). His doctoral thesis (1990) was based on the ‘Pathogenesis of dialysis-amyloidosis and the role of lymphocytes on beta-2-microglobulin synthesis and dialysis membranes’. Prof. Campistol has published more than 700 experimental and clinical papers in international peer-reviewed journals. He is a member of many international transplant societies, on the editorial board of a number of major international transplant journals and a principal investigator in numerous clinical studies. His current research interests include the use of new immunosuppressive regimens in renal transplantation, mechanisms of allograft fibrosis and renal regenerative medicine.

use of new immunosuppressive regimens in renal transplantation, mechanisms of allograft fibrosis and renal regenerative medicine.

Tetsuhiro Tanaka is a current employee at the Division of Nephrology and Endocrinology, the University of Tokyo School of Medicine.He graduated from the University of Tokyo School of Medicine in 1997 and obtained his PhD degree at the University of Tokyo Graduate School of Medicine in 2005. He received the Young Investigator Award of the Japanese Society of Nephrology in 2014. He is currently serving as an editorial board member of Kidney International and Clinical and Experimental Nephrology.

Role of chronic hypoxia and hypoxia-inducible gene transcription in the pathogenesis of CKD

Lavinia-Oltița Brătescu completed her Graduation at University of Medicine and Pharmacy from Timisoara, in Romania. From 2007, she worked as a Nephrologist at Sf. Pantelimon International Healthcare Systems Nephrology and Dialysis Medical Center, in Bucharest. From 2012, she became the Chief Physician of the same clinic. From January 2016, Dr. Lavinia-Oltița Brătescu is Chief Physician at Diaverum Morarilor Nephrology and Medical Center in Bucharest, Romania. She completed her PhD in November 2013. Her PhD thesis entitled “The role of iron and hepcidin in pathogenesis of anemia on hemodialysis patients”. For the first time in a study (published in Journal of Renal Nutrition), hepcidin-25 was measured using a commercial competitive ELISA method. Also, Dr. Brătescu has participated in national and international nephrology conference as a speaker and as poster presenter.

Nephrology and Dialysis

Dr. Abouchacra completed her Residency Training Program in Internal Medicine at University of Toronto, Canada and obtained her Canadian (F.R.C.P.) and American Boards (F.A.C.P.) in Internal Medicine in 1990. She went ahead with further training in nephrology at McGill University, Montreal, Canada and obtained the Canadian Royal College Certification and American Boards in Nephrology in 1992. She also did her 2-year Clinical Research Fellowship sponsored by the National Kidney Foundation of Canada which served as thesis for Masters in Science (MSc) at Institute of Medical Sciences, University of Toronto, Canada in 1995. Moreover, Dr. Abouchacra has an active membership of Royal College of Physicians of Canada and College of Physicians and Surgeons of Ontario and is a fellow of the American Society of Nephrology (FASN). She is also an affiliate member of the American Heart Association’s “Kidney Council”, member of the American Society of Nephrology as well as Emirates Medical Association of Nephrology. She has an extensive clinical experience in nephrology & internal medicine and has served as Chairperson of Nephrology Department at Tawam Hospital-JHMI till 2012 when she moved on to become Director of Tawam Outpatient Services. She is also the Chairperson for SEHA Urology & Kidney Disease Service Line Council and additionally holds the title of Clinical Professor at Faculty of Medicine and Health Sciences (FMHS) Al Ain, UAE. Dr Abouchacra previously served as the Chairperson of Academic Affairs Department at Tawam Hospital-JHMI from 2005 to October 2008. She also actively participates in teaching as well as research activities with numerous publications and scientific projects in peer reviewed journals.

Nephrology

The head of Institute for the Nuclear Medicine, Military Medical Academy, Belgrade. Prof. Dr Sc. Med of Nuclear Medicine. Born in Vrginmost, Croatia, February 1st, 1954. Graduated from the University of Belgrade in 1978, Nuclear Medicine specialization in 1984, and in London in 1987. He defends his doctoral thesis in the field of nuclear medicine in 1996. Instructor of Nuclear Medicine for Students Specializing in Internal Medicine and Surgery from 1985. Since 2004. the head of The Institute for the Nuclear Medicine, Military Medical Academy; since 2011. the head of The Group of Diagnostic Institutes at the Military Medical Academy; since 2012. professor in The Medical School of the Military Medical Academy for the course Nuclear Medicine; 2013. tenured professor for the course Nuclear Medicine. Has over 250 specialized and scientific published articles, in domestic and foreign journals, chapters in books: “The Lung Tumors,” 2000, and “Tc Generators,” 2003; author of the chapter in the textbook for the Medical School in the University of Thessaloniki, 2014; Ajdinović, B. at al., “Normal and pathological parathyroid glands,” Medical College, Belgrade, 2004; Ajdinović, B. at al, “Child with an urinary tract infection,” Belgrade, 2008; Ajdinović, B. at al, “Nuclear medicine - Textbook for students in The Medical School of the Military Medical Academy,” Belgrade, 2015. In charge of the nuclear medical research on kidneys in 1987, and, in 2006, of the research about the urinary tract infection in children; participates in the international project “Variability in DMS scintigraphy findings,” in 2007. From 2011 to 2014, participates in the project “Cellular and molecular pathogenetic mechanisms in disorders of reproduction and genital organs - prevention, diagnostics, and therapy” - subproject: “Treatment of antenatal hydronephrosis” of the Ministry of Science and Technological development; from 2011 to 2015, in charge of the project: Nuclear medical research of urinary tract in children: antenatal hydronephrosis, infection of urinary tract in children, and vesicoureteral reflux as causes of renal parenchymal disease. In 2001, awarded The Medal of White Angel from the president of the SR Yugoslavia; in 2008, “Author of the year” by the Military Sanitation Examination magazine; in 2011, awarded third prize at the first Medicinal Olympics in Thessaloniki, and in 2015, the first prize at the third Medicinal Olympics in Thessaloniki. Member of the World Association of Radiopharmacological and Molecular Therapy of the European Society of Nuclear Medicine, Serbian Medical Society, and the Society of Nuclear Medicine of Serbia.

Nuclear medicine

Professor Elisa Mieko Suemitsu Higa has graduated from Medical School in São Paulo, Brazil. After obtaining the Master and PhD degree at the Nephrology Division of Universidade Federal de São Paulo (UNIFESP), she has been at University of Colorado Health Sciences Center, in Denver, Colorado, USA, for a Post Doctoral Program, under Dr Robert W. Schrier supervision, for 2 ½ years . She obtained a specialization title for Nephrology and Intensive Care Medicine. Currently she is a Full Professor of Medicine Department at Universidade Federal de Sao Paulo, UNIFESP. She is the Chief of Nitric Oxide and Oxidative Stress Laboratory and she is involved in the Translational Medicine and Nephrology Post graduation Programs. In the Laboratory, she has currently 12 students under her supervision, including Research Initiation students (2), Master (7), PhD (2) and Post- doctoral (1) applicants. Prof Elisa is an elected Member of Physiology/ Physiopathology Department of Brazilian Society of Nephrology. She is a peer reviewer for Scientific Journals like PLOS ONE, Nitric oxide, ETAP, BMC Research Notes and Medical Principles and Practice. Research Lines: - Studies on pathophysiology of acute renal failure, diabetic nephropathy, aging and metabolic syndrome, targeting mainly on the role of nitric oxide, oxidative stress and inflammatory mediators. - Studies on alternative approaches for the treatment of chronic kidney diseases: exercises, probiotics and antioxidants. Abstract

nephrotoxicity

Dr.Abdelrahman Nimeri is head of the Division of General, Thoracic, & Vascular Surgery.He is the Director of Bariatric & Metabolic Institute (BMI) Abu Dhabi and Quality Review Officer of the department of Surgery Institute of Surgery

Surgery

Dr. K.L Gupta is the Chief of Nephrology in the premier Medical Institute i.e. Postgraduate Institute of Medical Education & Research, Chandigarh, India. After having done MBBS in 1976, he had passed MD(Medicine) in 1980 and then Doctorate of Nephrology (DM) in 1983. He is serving as the faculty member in the department of Nephrology at PGI, Chandigarh since 1983 and has over the years has made an excellent contribution different areas including the Clinical, Academics and Research. He has published more than 200 papers in reputed journals and written 10 chapters in different books. He has also been honored with various fellowships of National Academic of Nephrology in India, Royal College of Physicians, UK, and American Society of Nephrology etc.

He has interest in the area of fungal infections of the native kidney and following post-transplant lymphoproliferative disorders and Lupus Nephritis. He is President-Elect of Indian Society of Organ Transplantation, Vice President of Urology and Transplantation Society of SAARC Countries, past Indian Society of Nephrology, and an active member of International Society of Nephrology and the American Society of Nephrology.

R.G. Singh after doing his MD in Medicine and DM in Nephrology in 1982 from prestigious central university of Asia i.e. Banaras Hindu University joined as faculty at the institute of medical science where he has served as a Assist Prof., Asso Prof., Prof., Dean of faculty and Director of institute and finally he is serving as a lifelong Distinguished Prof. of nephrology at BHU and also Prof & Head of Nephrology in one of the upcoming institute of medical science, HIMS. Prof. Singh has published more than 350 papers in national and international journals, more than 3 dozen orations and has been conferred one dozen fellowships of different scientific bodies and organisations. He has conducted one and half dozen research projects and guided more than 3 dozen postgraduate students in medicine and nephrology. For last 20 years he has been involved in Tribal and Herbal medicine research.

NEPHROLOGY

Mianzhi Zhang has completed hisMD from Hebei MedicalUniversity. He has published more than 90 papers in reputed journals.He got the first prize of the provincescience and technology progress award in Tianjin; the fifteenth China youth five four medalandthe specialist of the special government allowances.Heisalsothe jury ofNational Natural Science Foundation.He participated in editing publications such as The Basic Theory of Zhang Daning's Traditional Chinese Medicine,The Research on Zhang Daning's Academic Thoughts,The Study on Zhang Daning's Methods Of The Kidney Invigorating And Blood Activating,The Progress Academic Thought on Zhang Daning,TheBasis And Clinical Treatment of Diabetic Nephropathy

Kidney

Sami has been trained at St Georges’ Hospital Medical School in London. He completed his basic surgical training in Yorkshire. Having a curious mind and an academic interest, he undertook a research fellowship at the Bristol Urological Institute with world experts in the field of lower urinary dysfunction, incontinence and urodynamics. Sami has gained broad experience in General Urology by joining the Southwest of England Specialist Registrar higher surgical training program. Sami was then appointed as a clinical instructor in Urology in the United State of America (USA). During a busy year at the University of Pittsburgh Medical Centre, Cleveland Clinic and the Arthur Smith Institute of Urology in New York, he developed special expertise in all aspects of Endourology treating all types of urinary stones (with laser, keyhole surgery and shockwave lithotripsy) as well as endoscopic treatment of upper tract urothelial kidney cancer. He was also trained in advanced urology techniques including laparoscopic and robotic surgery to treat kidney and prostate cancer. Sami had formal training as an expert witness. He has admitting rights to the Sprie Cambridge Lea, Cambridge Nuffield and Melberry Huntington hospitals. Being organised and a team player led Sami to take on several management and leadership roles. He is currently the UK board member for the International Young Urologist Association (IYUA), the local champion of the British Association of Urological Surgeons (BAUS) for Cambridge University Sami has acted as the UK trainees’ representative on the board of the European Society of Residents in Urology (ESRU) as well as the Senior Urology Registrars Group (SURG) representative on the Andrology executive committee for BAUS, a member of the International Continence Society Ethics Committee and a trainees’ representative for the British Medical Association (BMA) In his practice, Sami focuses on safe patients’ journey and ensures that high quality healthcare remains his main priority at all times. He believes that treatment should be individualized and tailored to patient’s preference in the context of up to date scientific evidence.

Urology

Rober Beelen has completed his PhD cum laude at the age of 30 years from VUmc. After a post-doc as special research fellow in Immunology at St Jude Childrens research Hospital (Memphis, TN, USA) he became a staff member at MCBI Vumc. He was appointed as full professor in cell biology in 2003 and has published more than 250 papers in reputed journals, half of them in the field of PD and was heavily funded by the Dutch Kidney Foundation. In 2011 he got a Marie Curie grant on EuTRiPD (European Training and Research in Peritoneal Dialysis) for 12 PhD students all-over Europe with academic, public and private partners resulting in new biomarkers and new clinical studies for patients on PD

Peritoneal dialysis

Dr. Golper has been practicing nephrology since 1978, and since 1999 at Vanderbilt University Medical Center. His career has been committed to the care of dialysis patients and the study of dialysis sciences. He is the author of 250 publications and has trained many other academic nephrologists. He is a Dialysis Editor for Up To Date.He has held positions on the Board of Directors of the RPA and AAKP, served as the PD Adequacy Work Group Chair for the first two versions of KDOQI, and remains on the Work Group. He led the Network 9 Peritonitis and Catheter Survival Study and has served on the ISPD Ad Hoc Committee for Peritonitis for many iterations of its guidelines. His interests remain in the field of dialysis and the administrative aspects of nephrology practice.

Nephrology and Hypertension

Dr Xiong Z. Ruan leads a research laboratory in UCL Centre for Nephrology which is one of the biggest renal-oriented lipid research laboratories in the world, and also act as the Director and Professor of Centre for Nephrology in Shenzhen University and the Joint Centre for Lipid Research in UCL-Chongqing Medical University. He received his Msc in Peking Union Medical College Hospital (PUMCH) in 1994 and PhD from University College London (UCL) in 1999. He is the Vice-President of Chinese Society of Renal Physiology and Associate Editor for BMC Nephrology. His major goal has been to develop an academic research programme cross UK and China that i) investigates the mechanisms of inflammatory stress accompanying with chronic kidney diseases in lipid trafficking control and ii) address clinical problems of lipid mediated tissue injuries associated with kidney disease ('Cardio Kidney Diabetes'). He has published more than 80 papers in Nature Rev Nephrol, J Am Soc Nephrol, Kidney Int, Lancet Diabete Endocrinology, Am J Physiol, Arterioscler Vasc Bio, and Hepatology etc.

Nephrology

Michelle James has completed her Masters in Science in Nursing at the University of Minnesota School of Nursing. She practiced as a bedside nurse on the Solid Organ Transplant unit at the Mayo Clinic for four years before moving to the University of Minnesota Health, where she held the role of Solid Organ Transplant Clinical Nurse Specialist for 11 years, before moving into the role of Clinical Director of Transplant Services, in which she has worked for the last 2 years. She has also served as the International Education Director for the International Transplant Nurses Society

Transplantation

Dr. Rula Abdulrahman graduated from the University of Baghdad, School of Medicine at the age of 23. Pursued an expansive medical career and research overseas, currently a PGY2 Internal Medicine resident at St. John`s Episcopal Hospital in Farrockaway New York. Dr. Abdulrahman worked as case manager and clinical supervisor in the Italian Red Cross to help the war victims in the middle east in 2003. Dr. Abdulrahman currently following a path of clinical research with multiple abstracts and case presentations while serving as a resident physician.

Hemodialysis

Xiu-Wu Han has completed his PhD from Capital Medical University, Beijing, China. He is the director of Department of Urology, Beijing Chaoyang Hospital Affiliated to Capital Medical University(western campus) Beijing 100020, China. , He has more than 20 years experiences of kidney transplantation and published more than 40 papers in Chinese and English.

Kidney Transplantation

Graduated in Medicine cum laude (1980) at University of “G. D’Annunzio” School of Medicine, Chieti, Italy, Dr. Arduini spent several years in various prestigious academic centers in the U.S. and in Italy (1981-1998). Afterword, Dr. Arduini left academia and joined Pharma Industry as head of the department of Metabolic Diseases in Sigma Tau Pharmaceutical Industries, Pomezia, Italy, and as disease area head of the department of Metabolic Diseases in Hoffman-La Roche, Basel, Switzerland. More recently, Dr. Arduini founded a couple of successful companies in Italy (Glomeria Therapeutics) and Switzerland (CoreQuest) engaged in the R&D and marketing of an innovative therapeutic platforms for the treatment of kidney and cardiac failure.

Kidney Treatment

Nikola M. Pavlovic graduated in 1974 at the Medical Faculty, University Nis, Serbia. 1979 - Bachelor of Medical Sciences, Medical Faculty Nis 1979 - Lecturer in Internal Medicine 1982 - Specialist in Internal Medicine 1982 – 1984 - British Council Scholar at the Royal Free hospital, London, Great Britain 1986 - Ph.D. of Medical Sciences 1988 - Associated Professor in Internal Medicine 1996 - Private medical and scientific activities Nikola M. Pavlovic has published more than 50 papers, most of them in reputed journals dealing with various problems related to kidney diseases. His current topic is lipid abnormalities, pathogenesis and exposure pathways in AAN and/or BEN

Kidney Diseases

Jia L. Zhuo, M.D., Ph.D. is a Tenured Full Professor and the Director of Receptor and Signal Transduction Laboratory in the Department of Pharmacology and Toxicology at the University of Mississippi Medical Center, Jackson, Mississippi, USA. Dr. Zhuo has over 30 years’ sponsored research experience on the roles of endocrine, paracrine, and intracrine angiotensin II in the kidney and hypertension, supported by National Health and Medical Research Council of Australia (NHMRC) and National Institute of Health (NIH). He has authored >110 peer-reviewed articles and book chapters with many recognized by editorials, cover highlights, and the Faculty of 1000. Dr. Zhuo is a Fellow of The American Association for The Advancement of Science (AAAS), American Heart Association (AHA), and American Society of Nephrology (ASN), a permanent member for NIH/Center for Scientific Review Hypertension and Microcirculation Study Section. His research is currently supported by grants from National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of General Medical Sciences (NIGMS), and National Heart, Lung, and Blood Institute, respectively.

His research is currently supported by grants from National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of General Medical Sciences (NIGMS), and National Heart, Lung, and Blood Institute, respectively.

Leonardo Spatola got Medical Degree cum magna laude in 25th march 2009 at the University of Palermo, then he got Nephrology Specialization cum magna laude in 26th May 2015 at the University of Verona. He currently works as a Nephrologist in the Renal and Haemodialysis Unit at the Humanitas University in Milan (Italy). He is first author of several works indexed in Pubmed/Medline and he is referee for Kidney and Blood pressure Research Journal and Saudi Journal of Kidney Disease and Transplantation Journal.

He is first author of several works indexed in Pubmed/Medline and he is referee for Kidney and Blood pressure Research Journal and Saudi Journal of Kidney Disease and Transplantation Journal.

Takeo Ishii has completed his PhD at the age of 28 years from Jikei University School of Medicine, Tokyo. He is now the co-director of Yokohama Daiichi Hospital, a central hospital of Zenjinkai Group. Zenjinkai Group is consisting from 51 hemodialysis clinics and health check up centers. He is also a reserch fellow of Department of Medical Science and Cardiorenal Medicine, Yokohama City University, Graduate school of Medicine. He received award from Japanese Society of Nephrology. The award wining study was dialysis outcome study and he read this paper at EDTA-ERA 2017.

He is also a reserch fellow of Department of Medical Science and Cardiorenal Medicine, Yokohama City University, Graduate school of Medicine.

Xiu-Wu Han has completed his PhD from Capital Medical University, Beijing, China. He is the director of Department of Urology, Beijing Chaoyang Hospital Affiliated to Capital Medical University(western campus) Beijing 100020, China. , He has more than 20 years experiences of kidney transplantation and published more than 40 papers in Chinese and English.

Nephrology

Prof. Himansu Sekhar Mahapatra has completed his DM (Nephrology) from AIIMS, New Delhi and now working as Head of the Department of Nephrology at PGIMER, Dr R.M.L.Hospital, New Delhi, India. He trained many of the post graduate students of Nephrology and published more than 22 papers in reputed journals and has been serving as an editorial board member of repute. XX Dr Sunil Kumar Dakh is the DM (Nephrology) Post graduate student in Nephrology at PGIMER, Dr R.M.L.Hospital, New Delhi, India

Nephrology

Dr Xiong Z. Ruan leads a research laboratory in UCL Centre for Nephrology which is one of the biggest renal-oriented lipid research laboratories in the world, and also act as the Director and Professor of Centre for Nephrology in Shenzhen University and the Joint Centre for Lipid Research in UCL-Chongqing Medical University. He received his Msc in Peking Union Medical College Hospital (PUMCH) in 1994 and PhD from University College London (UCL) in 1999. He is the Vice-President of Chinese Society of Renal Physiology and Associate Editor for BMC Nephrology. His major goal has been to develop an academic research programme cross UK and China that i) investigates the mechanisms of inflammatory stress accompanying with chronic kidney diseases in lipid trafficking control and ii) address clinical problems of lipid mediated tissue injuries associated with kidney disease ('Cardio Kidney Diabetes'). He has published more than 80 papers in Nature Rev Nephrol, J Am Soc Nephrol, Kidney Int, Lancet Diabete Endocrinology, Am J Physiol, Arterioscler Vasc Bio, and Hepatology etc.

Nephrology and Urology

Dr Sudhaharan Sivathasan is a Consultant Physician and Nephrologist at Tuanku Ja'afar General Hospital in Seremban, Malaysia. He graduated from the University of Malaya in 2005 as the Gold Medalist of his batch. He completed his MRCP UK in 2009, and Board of Nephrology Examinations (Malaysia) in 2015 with the Best Candidate Book Prize. His interests include haemodialysis and general Nephrology, research and lecturing. He has presented in local and international conferences and won several Young Investigator Awards. He is an adjunct lecturer for International Medical University and Perdana University.

URO-NEPHROLOGY

Ronald has completed his MSN at the Kean University, New Jersey USA and is a Doctoral in Nursing Practice candidate (DNPc) at Case Western University School of Nursing. He is the hemodialysis and Apheresis Patient Care Director at New York Presbyterian Hospital-Columbia University Medical Center, Children’s Hospital of New York and The Allen Hospital, ranked #1 hospital in New York and tri-state area (New Jersey & Connecticut), ranked #6 in the USA and a world renowed organization. He has published several papers in reputed journals in Nephrology. Ronald has been in leadership position in nearly 10 years.

Hemodialysis

Gakuru Macharia is the Founder Kidney Research Kenya (KRK) KRK has been training doctors, nurses and surgeons through partnership Cairo University, Toledo University USA, Kings College London, Liverpool Teaching Hospital, Hunan Province China. Publisher Author of many books including – Kidney Failure, High Blood Pressure, Kidney Transplantation and Organ Donation, Dialysis, My own Experience. A Bio – Med and has worked for Toshiba Medical Systems Europe and NHS in the UK. He’s also a Journalist and has worked for Kenya Broadcasting as London Bureau Chief, commentator for Aljazeera, CNN, BBC etc.

Kidney Transplantation and Organ Donation, Dialysis

Josep M. Campistol is currently the General Director of the Hospital Clinic of Barcelona, Spain, and former Medical Director of the same hospital as well as Director of the Clinical Institute of Nephrology and Urology (ICNU). He is also Professor of Medicine at the Nephrology Department of the University of Barcelona. He received his medical degree from the University of Barcelona in 1983, and completed his residency in internal medicine and, subsequently, his fellowship in renal medicine at the Hospital Clinic of the same institution. Following his training as a fellow in renal medicine at the University of Barcelona, Prof. Campistol continued his clinical work in renal transplantation within the Renal Transplant Unit at the Hospital Clinic. During this period, he also developed research interests into the pathogenesis of dialysis-related amyloidosis, and undertook a visiting Fulbright Scholarship at Boston University School of Medicine in Boston, MA, USA (1991– 1992). His doctoral thesis (1990) was based on the ‘Pathogenesis of dialysis-amyloidosis and the role of lymphocytes on beta-2-microglobulin synthesis and dialysis membranes’. Prof. Campistol has published more than 700 experimental and clinical papers in international peer-reviewed journals. He is a member of many international transplant societies, on the editorial board of a number of major international transplant journals and a principal investigator in numerous clinical studies. His current research interests include the use of new immunosuppressive regimens in renal transplantation, mechanisms of allograft fibrosis and renal regenerative medicine.

use of new immunosuppressive regimens in renal transplantation, mechanisms of allograft fibrosis and renal regenerative medicine.

Tetsuhiro Tanaka is a current employee at the Division of Nephrology and Endocrinology, the University of Tokyo School of Medicine.He graduated from the University of Tokyo School of Medicine in 1997 and obtained his PhD degree at the University of Tokyo Graduate School of Medicine in 2005. He received the Young Investigator Award of the Japanese Society of Nephrology in 2014. He is currently serving as an editorial board member of Kidney International and Clinical and Experimental Nephrology.

Role of chronic hypoxia and hypoxia-inducible gene transcription in the pathogenesis of CKD

Lavinia-Oltița Brătescu completed her Graduation at University of Medicine and Pharmacy from Timisoara, in Romania. From 2007, she worked as a Nephrologist at Sf. Pantelimon International Healthcare Systems Nephrology and Dialysis Medical Center, in Bucharest. From 2012, she became the Chief Physician of the same clinic. From January 2016, Dr. Lavinia-Oltița Brătescu is Chief Physician at Diaverum Morarilor Nephrology and Medical Center in Bucharest, Romania. She completed her PhD in November 2013. Her PhD thesis entitled “The role of iron and hepcidin in pathogenesis of anemia on hemodialysis patients”. For the first time in a study (published in Journal of Renal Nutrition), hepcidin-25 was measured using a commercial competitive ELISA method. Also, Dr. Brătescu has participated in national and international nephrology conference as a speaker and as poster presenter.

Nephrology and Dialysis

Vladimirs Strazdins graduated from Riga Medical Institute in 1977 (now called Riga Stradins University). He served for two years as an Army Medical Officer and started to work in University Hospital for Children in Riga in 1983. In 1992, he was appointed as Head of Nephrology at the same hospital and held this position till 2009. He is a member of European Pediatric Dialysis Working Group under ESPN from 2004 till 2012, with published European Guidelines on Pediatric Dialysis. He is recently retired, but still working part-time in Hemodialysis Unit at MS Gailezers and provides second-opinion to the consulting patients. He currently focuses on antimicrobial resistence issues and its implications on urinary tract infections.

Dialysis and urinary tract infections

Prof. Petra Reinke is Nephrologist / Clinical Scientist - scientific topics: transplantation medicine, development of new diagnostic and therapeutic approaches in transplantation. She is Project coordinator for the EU founded FP7 consortium “BIO-DrIM”, was Steering committee member / work-package leader of the EU founded FP7 consortium “ONE- Study”, Steering committee member / work-package leader of the EU founded FP6 consortium “RISET”, Co-PI for a project founded by the Immune Tolerance Network, Co-Investigator ROTF grant. She is Head of the “Kidney Transplant Outpatient Clinic”; Head of research area “immune system”, Head of the GMP-Facility, Steering Committee Member of the Berlin-Brandenburg Center for Regenerative Therapies, of the DFG-sponsored Berlin-Brandenburg School for Regenerative Therapies, of the Berlin Institute of Health (BIH) Stem Cell Center. She published more than 300 articles.

Transplantation medicine

Thomas Ryzlewicz has completed his PhD from Free University in Berlin (West). He started dialysis treatment in 1974. In between 2 years in the Physiologic Institute (Berlin-West, theme acid-base status). In1978, he published two papers in Kidney International (co-working with H Hampl) concerning the cardio-vascular behavior during dialysis monitored by left-heart catheter. In 1978, he worked on the development of a rough protoype for bicarbonate dialysis in order to study the amount of acidification. In 1985, he was a Consultant at the Nephrologic Clinic in Regensburg (Bavaria, Germany). He was a Senior Consultant in 1992 (dialysis centre in Ebersberg, near Munich, Germany). He is responsible for handling of many prototypes of dialysis supply systems, e.g., prototypes of hemofiltration (1978) and of the real (2-step) online-hemofiltration (1983-85). He worked on the development of an own bloodline with minimal contact between blood & air in order to reduce the sheer-stress in single fibre capillary (big EPO dosage reduction, product “Oxyless-Line”) which obtained EU patent, US patent, PEMA audit from London, and was published by Ian Macdougal (King’s College, London)

Dialysis, Kidney Transplantation

Käthe B Meyer completed her Master’s and is currently completing her PhD at Oslo University. She is a Transplant Coordinator at Oslo University Hospital. She has been a member of several international committees such as the Executive Committee of the Board of Transplant Coordinators within the division of Transplantation of the UEMS, Chair of Nordic Transplant Coordinator Group and scientific committee member at EDTCO congresses. She has published 8 articles in reputed journals.

Transplantation and Kidney diseases

Dr. Amit Gupta is currently working as a Professor of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India. He is a Senior Resident in AIIMS New Delhi, India and fellow in Nephrology Guys Hospital, London, UK and Toronto Hospital, Toronto, Canada. He had qualifications of M.B.B.S; M.D. (Medicine), D.N.B (Nephrology) and FRCP (London). He has a 40 years of experience as a faculty member in Department of Nephrology, SGPGIMS, Lucknow, India joined in the year 1987. His main research and interest areas are Peritoneal Dialysis and Renal transplantation. He held various positions in various Societies, Past President Indian Society of Nephrology, 2009 and Past President Peritoneal Dialysis Society of India, 2004. And also he had orations in Khullar Oration of Indian Society of Nephrology 2005, Arogya Kalyan Nyas Oration of Peritoneal Dialysis Society of Nephrology 2012 and Georgi Abraham Oration of Peritoneal Dialysis Society of India 2016. He had 192 articles in indexed journals & 30 book chapters. And also he had a achievement in the CAPD programme at SGPGIMS in 1993 which is the largest centre for CAPD in South Asia.

Peritoneal Dialysis and Renal transplantation

Donald Silverberg Graduated from Medical School University of Manitoba in 1962. He did his Residency in Internal Medicine and Nephrology at the Mayo Clinic Rochester Minnesota in 1962-1966 and Residency in Nephrology, University of Lund, Sweden in 1966-1967. He worked as Nephrologist University Hospital, Edmonton Canada during l968-1976. Has been living in Israel and practicing nephrology since 1976 in Tel Hashomer and Beilinson and Tel Aviv Medical Center. National Director of Hypertension Control Division, Kupat Holim Sick Fund 1978-1986 (Organizing the detection and treatment of hypertension for the Israeli population)

Nephrology

Bruce Hendry is President of the UK Renal Association and Emeritus Professor of Renal Medicine at King's College London. He graduated in medicine from the University of Oxford and received his PhD in Biophysics from the University of Cambridge. His major research interests are in the cell and molecular biology of progressive renal fibrosis and in the design of novel therapeutic approaches. His current work is focused on the study of new approaches to the problem of aberrant renal cell proliferation leading to fibrosis; this work includes the use of antisense and small molecule strategies. Recent work has examined the role of antisense as therapy in renal fibrosis and ADPKD and the targeting of T-type calcium channels in glomerular disease. He has clinical research interests in diabetic nephropathy, HIV and the kidney and in polycystic kidney disease

Nephrology